Macrolides & Clindamycin: The 50S Blockers
A patient on a steady warfarin dose is given a common antibiotic for a chest infection — and days later starts bleeding, no dose changed. Another gets an antibiotic and develops a heart-rhythm scare. And a third recovers from a simple infection only to be struck by life-threatening diarrhoea. Three drugs, three hidden dangers — and all of them are captured in the story of the antibiotics that block the 50S ribosome.
A patient stable for years on warfarin is prescribed clarithromycin for a chest infection. Nobody touches the warfarin dose — yet within days his blood is dangerously over-thinned and he starts to bleed. The antibiotic didn't act on his clotting at all; it blocked the liver enzyme that normally clears his warfarin, so the warfarin quietly piled up. This is the same CYP interaction you met with grapefruit juice, and it's one of three signature dangers of the macrolide family. To use these excellent drugs safely, you have to know all three.
Macrolides: reach and reasons to worry
Macrolides bind the 50S ribosome, blocking protein synthesis. The macrolides — azithromycin, clarithromycin, and erythromycin — bind the 50S ribosomal subunit and block the ribosome from moving along its message, halting protein synthesis (bacteriostatic). Clinically they shine against respiratory infections and the atypical organisms (Mycoplasma, Legionella, Chlamydia), whooping cough, and as an alternative for strep in penicillin-allergic patients; clarithromycin is part of H. pylori treatment, and azithromycin's very long tissue half-life allows short, convenient courses. But three cautions define them. First, they prolong the QT interval — a real risk of the dangerous rhythm torsades, especially combined with other QT drugs. Second, erythromycin and clarithromycin are potent inhibitors of the CYP3A4 liver enzyme, so they raise the levels of many co-prescribed drugs (warfarin, statins, and more) — azithromycin is the exception, with few interactions. And third, gut upset is common, because erythromycin also stimulates the gut's motilin receptors (a quirk exploited to treat a sluggish stomach).
Clindamycin: anaerobes — and a notorious side effect
Clindamycin (a lincosamide) binds the very same 50S site, so it too blocks protein synthesis. Its niche is Gram-positive bacteria (including many community MRSA and streptococci) and, importantly, anaerobes — the bugs of abscesses, aspiration pneumonia, and deep soft-tissue infections. It has a second, elegant use: because it shuts down protein synthesis, it switches off the toxins that certain streptococci and staphylococci produce, so it's added to treat toxin-driven diseases like necrotizing fasciitis and toxic shock. But clindamycin carries one of the most famous side effects in all of antibiotics: it is the classic trigger of Clostridioides difficile colitis, a severe, sometimes life-threatening diarrhoea caused when the drug wipes out the protective gut flora and lets C. difficile overgrow. A powerful drug, shadowed by the gut it disturbs.
- Macrolides (azithromycin, clarithromycin, erythromycin) bind 50S → bacteriostatic.
- Great for respiratory & atypical infections; azithromycin allows short courses.
- Three dangers: QT prolongation, CYP3A4 inhibition (erythro/clarithro), GI upset.
- Clindamycin binds the same 50S site; covers Gram-positives & anaerobes; suppresses bacterial toxins.
- Clindamycin is the classic cause of C. difficile colitis.
Two drugs in this family are woven into earlier lessons. Clarithromycin and erythromycin are CYP3A4 inhibitors — the very same mechanism as grapefruit juice from the metabolism chapter — so they spike the levels of statins (risking muscle damage), warfarin (risking bleeding), and other CYP3A4 substrates. And their QT prolongation ties straight back to the cardiac action-potential article: block the heart's repolarizing potassium current, lengthen the QT, and risk torsades. Azithromycin, notably, is the macrolide with the fewest interactions — which is part of why it's so widely used.
- Prescribing clarithromycin/erythromycin with a statin or warfarin without adjusting — CYP3A4 inhibition.
- Combining a macrolide with other QT-prolonging drugs. Additive torsades risk.
- Forgetting clindamycin is a top cause of C. difficile colitis.
- Assuming all macrolides interact equally. Azithromycin has far fewer CYP interactions.
Which antibiotic is the classic trigger of Clostridioides difficile colitis?
- Macrolides & clindamycin bind the 50S ribosome (bacteriostatic).
- Macrolides: respiratory/atypical cover; beware QT prolongation, CYP3A4 inhibition, GI upset.
- Azithromycin has the fewest CYP interactions; clarithromycin/erythromycin the most.
- Clindamycin covers Gram-positives & anaerobes and suppresses toxins — but classically causes C. difficile.
- Katzung BG. Basic & Clinical Pharmacology — Macrolides, Clindamycin & Streptogramins.
- Brunton LL, et al. Goodman & Gilman's The Pharmacological Basis of Therapeutics — Macrolides & clindamycin.
- Rang HP, Dale MM, et al. Rang & Dale's Pharmacology — Macrolides & lincosamides.
- Murray PR, et al. Medical Microbiology — Protein synthesis inhibitors.
- Whalen K. Lippincott Illustrated Reviews: Pharmacology — Macrolides & clindamycin.
